CURE Epilepsy: Catalyst Award

Priority areas include:

• Innovative approaches to prevent, modify and/or arrest the development of acquired epilepsy.
• Development of novel approaches to prevent the onset or halt the progression of severe pediatric epilepsies.
• New, effective treatments for the >30% of the epilepsy population who are pharmaco-resistant.
• Translational or clinical approaches aimed at normalizing sleep disturbances or circadian rhythms to treat seizures.
• New approaches, biomarkers, or therapies to predict and/or prevent SUDEP.

Funding: up to $250,000 over 2 years. No Overhead - Please contact the research authority if planning to submit.

https://www.cureepilepsy.org/grants-program/